Pharmaceutical preparation
AssigneeBechgaard International Research and Development A/S
InventorsErik Bechgaard, Sveinbjorn Gizurarson, Rolf K. Hjortkjaer
Life of this patent
Estimating the term…
Abstract
A pharmaceutical preparation for application of an effective amount of one or more biologically active substance(s) to a mucosal membrane of a mammal comprising an n-glycofurol represented by the formula I: ##STR1## wherein n is 1 to 4 in an amount from: 0.1-30% preferably 0.1-20% most preferably 1-15% in water, or in vegetable oil or n-ethylene glycol(s) represented by formula II: H(OCH.sub.2 CH.sub.2).sub.p OH wherein p is 2 to 8, or in a mixture thereof. Nasal administration of the preparation produces a high plasma concentration of the pharmaceutically active substance(s) nearly as rapid as by i.v. administration.
Claims29
A method for administering a therapeutically effective amount of a biologically active substance to the circulatory system of a mammal comprising administering a pharmaceutical composition having a total volume of 1-1000 .mu.l to a nasal mucosal membrane of the mammal, the pharmaceutical composition comprising the therapeutically effective amount of the biologically active substance dissolved or suspended in a volume of 1-1000 .mu.l of a n-glycofurol-containing vehicle comprising 0.1-30% of at least one n-glycofurol represented by the formula:
- ##STR5## wherein n is from 1 to 4, the vehicle further comprising a component selected from the group consisting of water, vegetable oil, n-ethylene glycol(s) represented by the formula II:
- H(OCH.sub.2 CH.sub.2).sub.p OH
- wherein p is 3 to 8, and mixtures thereof, so that upon administration of the pharmaceutical composition to the nasal mucosal membrane, absorption of the biologically active substance through the mucosal membrane and into the blood stream of the mammal rapidly takes place and thereby allows the biologically active substance to exert its therapeutic effect.
A pharmaceutical composition for administering a biologically active substance through a nasal mucosal membrane of a mammal, comprising an effective amount of the biologically active substance(s) suspended or dissolved in a volume of 1-1000 .mu.l of a n-glycofurol-containing vehicle comprising 65-98% of at least one n-glycofurol represented by the formula:
- ##STR6## wherein n is from 1 o 4, the vehicle further comprising a component selected from the group consisting of water, vegetable oil, n-ethylene glycol(s) represented by the formula II:
- H(OCH.sub.2 CH.sub.2).sub.p OH
- wherein p is 3 or 4, and mixtures thereof.
A pharmaceutical composition for administering a biologically active substance through a nasal mucosal membrane of a mammal, comprising an effective amount of the biologically active substance(s) suspended or dissolved in a volume of 1-1000 .mu.l of a n-glycofurol-containing vehicle consisting essentially of 100% of at least one n-glycofurol represented by the formula:
- ##STR7## wherein n is from 1 to 4.
Dependencies are inferred from the claim text.